Physiological agonism and antagonism

Physiological agonism describes the action of a substance which ultimately produces the same effects in the body as another substance—as if they were both agonists at the same receptor—without actually binding to the same receptor. Physiological antagonism describes the behavior of a substance that produces effects counteracting those of another substance (a result similar to that produced by an antagonist blocking the action of an agonist at the same receptor) using a mechanism that does not involve binding to the same receptor.

Examples

Physiological agonists

Epinephrine induces platelet aggregation, and so does hepatocyte growth factor (HGF).[1] Thus, they are physiological agonists to each other.

Physiological antagonists

There are several substances that have antihistaminergic action despite not being ligands for the histamine receptor. For instance, epinephrine raises arterial pressure through vasoconstriction mediated by A1-adrenergic receptor activation, in contrast to histamine, which lowers arterial pressure. Thus, despite not being true antihistamines because they do not bind to and block the histamine receptor, epinephrine and other such substances are physiological antagonists to histamine.

References

Pietrapiana, D; Sala, M; Prat, M; Sinigaglia, F (Aug 15, 2005). "Met identification on human platelets: role of hepatocyte growth factor in the modulation of platelet activation". FEBS Letters. 579 (20): 4550–4. doi:10.1016/j.febslet.2005.06.072. PMID 16083876. S2CID 39722975.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[pmid_16083876-1] Pietrapiana, D; Sala, M; Prat, M; Sinigaglia, F (Aug 15, 2005). "Met identification on human platelets: role of hepatocyte growth factor in the modulation of platelet activation". FEBS Letters. 579 (20): 4550–4. doi:10.1016/j.febslet.2005.06.072. PMID 16083876. S2CID 39722975.